Astrana Health, Inc. Reports Fourth Quarter and Year-End 2024 Results Company to Host Conference Call on Thursday

Astrana Health, Inc. Reports Fourth Quarter

and Year-End 2024 Results

Company to Host Conference Call on Thursday,

February 27, 2025, at 2:30 p.m. PT/5:30 p.m. ET

ALHAMBRA, Calif., February 27, 2025 /PRNewswire/

-- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company")

(NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality,

and high-value care to all, today announced its consolidated financial results for the fourth quarter and year ended December 31,

"Astrana Health's strong performance

in 2024 highlights the strength of our patient-centered, payer-agnostic platform and our unwavering commitment to delivering high-quality,

accessible care. Our significant growth and geographic expansion, alongside robust financial performance, are a direct result of our disciplined

execution across the four pillars of the Astrana playbook, " said President and CEO of Astrana, Brandon K. Sim.

"Looking ahead, we remain focused on growing

membership sustainably, further improving quality of care for our membership while responsibly managing costs, growing the 73% of our

capitated revenue that now comes from full-risk arrangements, and driving operating leverage and integration of recently acquired assets.

We are confident that our platform, combined with our proven ability to navigate industry headwinds and a favorable outlook on future

reimbursement rates, will continue delivering sustainable, long-term value for all our stakeholders - patients, physicians, providers,

payers, and shareholders."

Financial Highlights for Year Ended December 31,

All comparisons are to the year ended December 31,

2023 unless otherwise stated.

(1) See "Reconciliation of Net

Income to EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin" and "Use of Non-GAAP Financial Measures" below for additional

Financial Highlights for the Fourth Quarter

All comparisons are to the quarter ended December 31,

2023 unless otherwise stated.

(1) See "Reconciliation of Net

Income to EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin" and "Use of Non-GAAP Financial Measures" below for additional

Recent Operating Highlights

Segment Results for the Year Ended December 31,

All comparisons are to the year ended December 31,

2023 unless otherwise stated.

(1) Balance includes general and administrative

expenses and depreciation and amortization.

(2) Income from operations for the

intersegment elimination represents rental income from segments renting from other segments. Rental income is presented within other income

which is not presented in the table.

Astrana is providing the following guidance for

total revenue and Adjusted EBITDA, based on the Company's existing business, current view of existing market conditions and assumptions

for the year ending December 31, 2025. The following guidance includes approximately $15 million in expected costs associated with continued

strategic investments in automation and AI, as well as ongoing and expected integration costs associated with planned acquisitions, but

does not include contributions from any acquisitions which have not yet closed.

See "Guidance Reconciliation of Net Income

to EBITDA and Adjusted EBITDA" and "Use of Non-GAAP Financial Measures" below for additional information. There can

be no assurance that actual amounts will not be materially higher or lower than these expectations. See "Forward-Looking Statements"

below for additional information.

Conference Call and Webcast Information:

Astrana will host a conference call at 2:30 p.m.

PT/5:30 p.m. ET today (February 27, 2025), during which management will discuss the results of the fourth quarter and year ended December 31,

2024. To participate in the conference call, please use the following dial-in numbers about 5 minutes prior to the scheduled conference

U.S. & Canada (Toll-Free): +1 (877) 858-9810

International (Toll): +1 (201) 689-8517

The conference call can also be accessed via webcast at:

An accompanying slide presentation will be available

in PDF format on the "IR Calendar" page of the Company's website (https://ir.astranahealth.com/news-events/ir-calendar)

after issuance of the earnings release and will be furnished as an exhibit to Astrana's current report on Form 8-K to be filed

with the SEC, accessible at www.sec.gov.

Those who are unable to attend the live conference

call may access the recording at the above webcast link, which will be made available shortly after the conclusion of the call.

Note About Consolidated Entities

The Company consolidates entities in which it

has a controlling financial interest. The Company consolidates subsidiaries in which it holds, directly or indirectly, more than 50% of

the voting rights, and variable interest entities ("VIEs") in which the Company is the primary beneficiary. Noncontrolling

interests represent third party equity ownership interests in the Company's consolidated entities (including certain VIEs). The

amount of net income attributable to noncontrolling interests is disclosed in the Company's consolidated statements of income.

Note About Stockholders' Equity,

Certain Treasury Stock and Earnings Per Share

As of the date of this press release, 41,048 holdback

shares have not been issued to certain former shareholders of the Company's subsidiary, Astrana Health Management, Inc. ("AHM"),

formerly known as Network Medical Management, Inc., who were AHM shareholders at the time of closing of the merger, as they have yet to

submit properly completed letters of transmittal to Astrana in order to receive their pro rata portion of Astrana's common stock

and warrants as contemplated under that certain Agreement and Plan of Merger, dated December 21, 2016, among Astrana, AHM, Apollo Acquisition

Corp. ("Merger Subsidiary") and Kenneth Sim, M.D., as amended, pursuant to which Merger Subsidiary merged with and into AHM,

with AHM as the surviving corporation. Pending such receipt, such former AHM shareholders have the right to receive, without interest,

their pro rata share of dividends or distributions with a record date after the effectiveness of the merger. The Company's consolidated

financial statements have treated such shares of common stock as outstanding, given the receipt of the letter of transmittal is considered

perfunctory and Astrana is legally obligated to issue these shares in connection with the merger.

Shares of Astrana's common stock owned by

Allied Physicians of California, a Professional Medical Corporation ("APC"), a VIE of the Company, are legally issued and

outstanding but excluded from shares of common stock outstanding in the Company's consolidated financial statements, as such shares

are treated as treasury shares for accounting purposes. Such shares, therefore, are not included in the number of shares of common stock

outstanding used to calculate the Company's earnings per share.

About Astrana Health, Inc.

Astrana Health, Inc. ("Astrana") is

a leading physician-centric, technology-powered, risk-bearing healthcare management company. Leveraging its proprietary population health

management and healthcare delivery platform, Astrana operates an integrated, value-based healthcare model, which aims to empower the providers

in its network to deliver the highest quality of care to its patients in a cost-effective manner. Together with our affiliated physician

groups and consolidated entities, we provide coordinated outcomes-based medical care in a cost-effective manner.

Headquartered in Alhambra, California, Astrana

serves over 10,000 providers and approximately 1.1 million patients in value-based care arrangements. Its subsidiaries and affiliates

include management services organizations (MSOs), a network of risk-bearing organizations ("RBOs") that encompasses independent

practice associations ("IPAs"), accountable care organizations ("ACOs"), and state-specific entities such as Restricted

Knox-Keene licensed health plans in California, and care delivery entities across primary, multi-specialty, and ancillary care. For more

information, please visit www.astranahealth.com.

Forward-Looking Statements

This press release contains forward-looking

statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements about the Company's guidance